The present disclosure provides vaccine compositions and methods for inducing a systemic immune response and a mucosal immune response, wherein the vaccine compositions include an antigen and a hepatitis B core virus-like particle (HBc VLP) as an adjuvant. The vaccine compositions are suitable for administration to the mucosal surface of a subject, and are effective in eliciting a protective immune response against infection.